Immuneering Corp. (IMRX)
5.27
-0.05
(-0.94%)
USD |
NASDAQ |
Mar 26, 13:33
Immuneering Cash from Investing (Quarterly) : -88.72M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 44.87M |
| Verastem, Inc. | -1.345M |
| Phathom Pharmaceuticals, Inc. | -0.087M |
| Tango Therapeutics, Inc. | -135.72M |
| X4 Pharmaceuticals, Inc. | 16.85M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.841M |
| Cash from Financing (Quarterly) | -0.3575M |
| Free Cash Flow | -45.49M |
| Free Cash Flow Per Share (Quarterly) | -0.1543 |
| Free Cash Flow to Equity (Quarterly) | -9.873M |
| Free Cash Flow to Firm (Quarterly) | -9.964M |
| Free Cash Flow Yield | -19.64% |